Cell therapy: a challenge in modern medicine

Cosimo De Bari, Francesco Dell'accio

Research output: Contribution to journalSpecial issue

17 Citations (Scopus)

Abstract

Cell therapies are unique in that the active component consists of living cells, which are difficult to define in their pharmacologic characteristics, and which produce variable and largely unknown amounts of bioactive molecules. Thus, the definition of the composition of a cellular product, mechanisms of action, pharmacokinetics, toxicity and efficacy assessment represent challenges never previously faced by traditional pharmacology. A pressing need for a routine use of cell therapies in the clinic is the development of quality controls for efficacy on the basis of clinically relevant potency assays, with prospective validation in human clinical trials. This review will focus on cell-based protocols for joint surface repair. In particular, we will present the case of autologous chondrocyte implantation as an example of advanced tissue engineering technology in the clinic, with the assumption that many issues discussed can be extrapolated to other cell-based approaches in regenerative medicine.
Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalBio-Medical Materials and Engineering
Volume18
Issue numberSupplement 1
Publication statusPublished - 1 Jan 2008
Event3rd International Meeting on Medical Engineering and Therapy - Nancy, France
Duration: 15 May 200616 May 2006

Fingerprint

Pharmacokinetics
Engineering technology
Tissue engineering
Medicine
Quality control
Toxicity
Assays
Repair
Cells
Molecules
Chemical analysis
Regenerative Medicine

Keywords

  • cartilage, articular
  • cell culture techniques
  • chondrocytes
  • clinical medicine
  • humans
  • internationality
  • quality assurance, health care
  • tissue engineering
  • regenerative medicine
  • stem cells
  • cartilage repair
  • mesenchymal stem-cells
  • autologous chondrocyte implantation
  • human articular chondrocytes
  • full-thickness defects
  • cartilage in-vivo
  • bone-marrow
  • synovial-membrane
  • phenotypic stability
  • repair tissue
  • transplantation

Cite this

Cell therapy : a challenge in modern medicine. / De Bari, Cosimo; Dell'accio, Francesco.

In: Bio-Medical Materials and Engineering, Vol. 18, No. Supplement 1, 01.01.2008, p. 11-17.

Research output: Contribution to journalSpecial issue

De Bari, C & Dell'accio, F 2008, 'Cell therapy: a challenge in modern medicine' Bio-Medical Materials and Engineering, vol. 18, no. Supplement 1, pp. 11-17.
De Bari, Cosimo ; Dell'accio, Francesco. / Cell therapy : a challenge in modern medicine. In: Bio-Medical Materials and Engineering. 2008 ; Vol. 18, No. Supplement 1. pp. 11-17.
@article{4f46d0d224f74c62b2d59db4711375a0,
title = "Cell therapy: a challenge in modern medicine",
abstract = "Cell therapies are unique in that the active component consists of living cells, which are difficult to define in their pharmacologic characteristics, and which produce variable and largely unknown amounts of bioactive molecules. Thus, the definition of the composition of a cellular product, mechanisms of action, pharmacokinetics, toxicity and efficacy assessment represent challenges never previously faced by traditional pharmacology. A pressing need for a routine use of cell therapies in the clinic is the development of quality controls for efficacy on the basis of clinically relevant potency assays, with prospective validation in human clinical trials. This review will focus on cell-based protocols for joint surface repair. In particular, we will present the case of autologous chondrocyte implantation as an example of advanced tissue engineering technology in the clinic, with the assumption that many issues discussed can be extrapolated to other cell-based approaches in regenerative medicine.",
keywords = "cartilage, articular, cell culture techniques, chondrocytes, clinical medicine, humans, internationality, quality assurance, health care, tissue engineering, regenerative medicine, stem cells, cartilage repair, mesenchymal stem-cells, autologous chondrocyte implantation, human articular chondrocytes, full-thickness defects, cartilage in-vivo, bone-marrow, synovial-membrane, phenotypic stability, repair tissue, transplantation",
author = "{De Bari}, Cosimo and Francesco Dell'accio",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "18",
pages = "11--17",
journal = "Bio-Medical Materials and Engineering",
issn = "0959-2989",
publisher = "IOS Press",
number = "Supplement 1",

}

TY - JOUR

T1 - Cell therapy

T2 - a challenge in modern medicine

AU - De Bari, Cosimo

AU - Dell'accio, Francesco

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Cell therapies are unique in that the active component consists of living cells, which are difficult to define in their pharmacologic characteristics, and which produce variable and largely unknown amounts of bioactive molecules. Thus, the definition of the composition of a cellular product, mechanisms of action, pharmacokinetics, toxicity and efficacy assessment represent challenges never previously faced by traditional pharmacology. A pressing need for a routine use of cell therapies in the clinic is the development of quality controls for efficacy on the basis of clinically relevant potency assays, with prospective validation in human clinical trials. This review will focus on cell-based protocols for joint surface repair. In particular, we will present the case of autologous chondrocyte implantation as an example of advanced tissue engineering technology in the clinic, with the assumption that many issues discussed can be extrapolated to other cell-based approaches in regenerative medicine.

AB - Cell therapies are unique in that the active component consists of living cells, which are difficult to define in their pharmacologic characteristics, and which produce variable and largely unknown amounts of bioactive molecules. Thus, the definition of the composition of a cellular product, mechanisms of action, pharmacokinetics, toxicity and efficacy assessment represent challenges never previously faced by traditional pharmacology. A pressing need for a routine use of cell therapies in the clinic is the development of quality controls for efficacy on the basis of clinically relevant potency assays, with prospective validation in human clinical trials. This review will focus on cell-based protocols for joint surface repair. In particular, we will present the case of autologous chondrocyte implantation as an example of advanced tissue engineering technology in the clinic, with the assumption that many issues discussed can be extrapolated to other cell-based approaches in regenerative medicine.

KW - cartilage, articular

KW - cell culture techniques

KW - chondrocytes

KW - clinical medicine

KW - humans

KW - internationality

KW - quality assurance, health care

KW - tissue engineering

KW - regenerative medicine

KW - stem cells

KW - cartilage repair

KW - mesenchymal stem-cells

KW - autologous chondrocyte implantation

KW - human articular chondrocytes

KW - full-thickness defects

KW - cartilage in-vivo

KW - bone-marrow

KW - synovial-membrane

KW - phenotypic stability

KW - repair tissue

KW - transplantation

M3 - Special issue

VL - 18

SP - 11

EP - 17

JO - Bio-Medical Materials and Engineering

JF - Bio-Medical Materials and Engineering

SN - 0959-2989

IS - Supplement 1

ER -